Esperion Therapeutics, Inc. (ESPR)

2.785 -0.12 (-4.30%) USD  |  NASDAQ  |  Mar 04, 12:49
More

Esperion Therapeutics Gross PP&E (Quarterly)

Gross PP&E (Quarterly) Chart

View Gross PP&E (Quarterly) for ESPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross PP&E (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Gross PP&E (Quarterly) Range, Past 5 Years

View Gross PP&E (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross PP&E (Quarterly) Benchmarks

View Gross PP&E (Quarterly) Benchmarks
Start Trial
Nektar Therapeutics --
Rigel Pharmaceuticals, Inc. --
Harrow, Inc. Upgrade
AnaptysBio, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade